Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease
NCT05130983
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment challenges.
Conditions
Crohn Disease
Inflammatory Bowel Diseases
Interventions
BIOLOGICAL:
ExoFlo
Sponsor
Direct Biologics, LLC